Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | See Remarks | March 01, 2020 | March 03, 2020 |
| PATTERSON COMPANIES, INC.PDCO · Entity 80730 | Director | September 18, 2017 | September 20, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date March 01, 2020 · Filed March 03, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 66,051 |
Ending reported balance
After 2020-03-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-03-01 · Tax withholding · Disposed 579 · Balance 57,051 F1: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Row 2 · 2020-03-02 · Grant · Acquired 9,000 · Balance 66,051 F2: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 2, 2020, one-third vesting on March 2, 2021, one-third vesting on March 2, 2022, and the remaining vesting on March 2, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan.
F2: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 2, 2020, one-third vesting on March 2, 2021, one-third vesting on March 2, 2022, and the remaining vesting on March 2, 2023.
PATTERSON COMPANIES, INC.
Report date September 18, 2017 · Filed September 20, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,546 |
Reported balance
After 2017-09-18 transaction · row 1
1 source rowRow 1 · 2017-09-18 · Grant · Acquired 3,058 · Balance 15,546 F1: Shares of Restricted Stock awarded to Non-Employee Directors as an Annual Grant pursuant to the Patterson Companies, Inc. 2015 Omnibus Incentive Plan. |
| Director Stock OptionsSEC Table II · derivative / convertible security | Direct | 7,000 |
Reported balance
Holding disclosure · report date 2017-09-18 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 7,000 F2: Options granted as follows: 7,000 on 3/17/2014 at $41.55. F3: Options exercisable as follows: 3,000 on 3/17/2016 and 4,000 on 3/17/2017. F4: All options expire 10 years after grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Restricted Stock awarded to Non-Employee Directors as an Annual Grant pursuant to the Patterson Companies, Inc. 2015 Omnibus Incentive Plan.
F2: Options granted as follows: 7,000 on 3/17/2014 at $41.55.
F3: Options exercisable as follows: 3,000 on 3/17/2016 and 4,000 on 3/17/2017.
F4: All options expire 10 years after grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2020 Filed Mar 3, 2020 17:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000124 · edgar.xml · nonDerivative · entry 2 LIN SARENA S · CIK 0001598788 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,051 F2 · price: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 2, 2020, one-third vesting on March 2, 2021, one-third vesting on March 2, 2022, and the remaining vesting on March 2, 2023. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 17:38 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 579 | $27.40 | $15,864.60 |
DisclosureSEC source: 0000950138-20-000124 · edgar.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,051 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| February 01, 2020 Filed Feb 4, 2020 16:23 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 4,183 | $30.90 | $129,254.70 |
DisclosureSEC source: 0000950138-20-000051 · edgar.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,630 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 12, 2019 Filed Mar 14, 2019 18:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 28,698 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000146 · edgar.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,813 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 12, 2019, with 14,133 vesting on February 1, 2020 and 14,565 vesting on February 1, 2021. Awards issued in replacement of previously held awards with respect to shares of common stock of Eli Lilly & Company (Lilly), which were forfeited in connection with the completion of an exchange offer on March 11, 2019 by Lilly, in which Lilly disposed of all of Elanco's shares held by it. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:56 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,136 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000115 · edgar.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,115 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2019, one-third vesting on March 1, 2020, one-third vesting on March 1, 2021, and the remaining vesting on March 1, 2022. Read SEC document |
| October 20, 2018 Filed Oct 23, 2018 18:57 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantNon-Qualified Stock Option (Right-to-Buy) · Derivative | 21,086 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0000950138-18-000568 · edgar.xml · derivative · entry 2 LIN SARENA S · CIK 0001598788 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,086 Underlying: Elanco Animal Health Inc. Common Stock · 21,086 shares Expires 2028-10-20 F2 · price: Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. F2 · derivative.exercise_date: Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. Read SEC document |
| October 20, 2018 Filed Oct 23, 2018 18:57 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 6,979 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-18-000568 · edgar.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,979 F1 · shares: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021. Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 16:24 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 20,000 | $24.00 | $480,000.00 |
DisclosureSEC source: 0001140361-18-039164 · form4.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| September 18, 2017 Filed Sep 20, 2017 10:09 UTC | PATTERSON COMPANIES, INC. PDCO · Entity 80730 | GrantCommon Stock | 3,058 | $37.94 | $116,020.52 |
DisclosureSEC source: 0001209191-17-053426 · doc4.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,546 F1 · kind: Shares of Restricted Stock awarded to Non-Employee Directors as an Annual Grant pursuant to the Patterson Companies, Inc. 2015 Omnibus Incentive Plan. Read SEC document |
| June 06, 2017 Filed Jun 7, 2017 12:05 UTC | PATTERSON COMPANIES, INC. PDCO · Entity 80730 | Exercise / conversionDirector Stock Options · Derivative | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-038256 · doc4.xml · derivative · entry 2 LIN SARENA S · CIK 0001598788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 2,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Options granted as follows: 9,000 on 3/17/2014 at $41.55. F2 · derivative.exercise_date: Options exercisable as follows: 1,000 on 3/17/2015, 4,000 on 3/17/2016, 4,000 on 3/17/2017. F3 · derivative.expiration_date: All options expire 10 years after grant date. Read SEC document |
| June 06, 2017 Filed Jun 7, 2017 12:05 UTC | PATTERSON COMPANIES, INC. PDCO · Entity 80730 | Exercise / conversionCommon Stock | 2,000 | $41.55 | $83,100.00 |
DisclosureSEC source: 0001209191-17-038256 · doc4.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 17:36 UTC | PATTERSON COMPANIES, INC. PDCO · Entity 80730 | GrantCommon Stock | 2,534 | $45.78 | $116,006.52 |
DisclosureSEC source: 0001209191-16-141216 · doc4.xml · nonDerivative · entry 1 LIN SARENA S · CIK 0001598788 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,488 F1 · kind: Shares of Restricted Stock awarded to Non-Employee Directors as an Annual Grant pursuant to the Patterson Companies, Inc. 2015 Omnibus Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.